The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial
Sign Up to like & getrecommendations! Published in 2018 at "Trials"
DOI: 10.1186/s13063-017-2406-5
Abstract: BackgroundAlzheimer’s disease (AD) is characterized not only by cognitive and functional decline, but also often by the presence of neuropsychiatric symptoms. Apathy, which can be defined as a lack of motivation, is one of the… read more here.
Keywords: apathy dementia; trial; methylphenidate trial; admet ... See more keywords